You have 9 free searches left this month | for more free features.

City

Brussels (1)

Minneapolis (1)

Condition

Infertility (2)

Graft vs Host Disease (1)

In Vitro Fertilization (1)

OHSS (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Masonic Cancer Center, University of Minnesota (1)

Organon and Co (1)

Universitair Ziekenhuis Brussel (1)

Collaborator

Intervention

pregnyl® (3)

cryobiosystem® (1)

intensified luteal phase support for fresh embryo transfer (1)

org 36286 (1)

orgalutran® (1)

progynova® (1)

puregon® (1)

utrogestan® (1)

vitrification with subsequent-cycle embryo thawing/transfer (1)

Study Documents

CSR Synopsis (1)

Intervention Type

drug (3)

device (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

pregnyl®

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GVHD Trial in Minneapolis (Pregnyl®)

Active, not recruiting

Graft vs Host Disease

Pregnyl®

Minneapolis, Minnesota

Masonic Cancer Center at University of Minnesota

Jan 3, 2022

Infertility, In Vitro Fertilization Trial (Org 36286, Puregon®, Orgalutran®)

Completed

Infertility
In Vitro Fertilization

Org 36286
+3 more

(no location specified)

Feb 1, 2022

Infertility, OHSS Trial in Brussels (procedure, drug, device)

Completed

Infertility
OHSS

Vitrification with subsequent-cycle embryo thawing/transfer
+5 more

Brussels, Lisboa, Belgium

Universitair Ziekenhuis Brussel

Mar 8, 2018